Vilin Bio Med Limited is actively involved in the domestic production of pharmaceutical products, operating its manufacturing facility in Roorkee, Uttarakhand. To ensure its competitiveness and contribute to the healthcare sector, the company has established a foundation for research and development, along with a cutting-edge manufacturing facility in Roorkee.
The sales strategy revolves around bulk selling of products to pharmaceutical manufacturers, marketers, and traders who serve as intermediaries to reach customers. These products primarily cater to other pharmaceutical companies and traders, who subsequently market them to distributors and retail customers. The company does not market its products under any specific brand name.
The main categories of products encompass various forms such as solid oral dosage (beta & non-beta-lactam), oral liquids, external preparations, and dry powders. The company’s promoters, namely Mr. Sadhanala Venkata Rao, Mr. Viswa Prasad Sadhanala, Mr. D. Srinivasa Reddy, and Mr. Anuj Bajpai, actively engage in day-to-day business operations and provide strategic guidance based on their extensive industry knowledge and market understanding.
The company’s competitive advantages lie in its skilled management team and dedicated workforce. The management possesses profound expertise in the pharmaceutical manufacturing sector, effectively handling operational challenges, devising business strategies, and addressing market dynamics. Also, Vilin Bio Med Limited places significant focus on quality assurance and maintains an in-house testing laboratory to assure compliance with both domestic and international quality standards.
The business strategy of the company centers around enhancing production capacity by utilizing the remaining 70% of capacity, optimizing operational efficiency, upholding quality control and assurance measures, and expanding the customer base. The company aims to strengthen customer relationships and bolster sales in existing markets, while simultaneously expanding its distribution network to tap into new geographical areas and customer segments.
Vilin Bio Med Limited IPO Complete Details:
| IPO Date | 16 June 2023 to 21 June 2023 |
| Issue Type | Fixed Price Issue IPO |
| Listing At | NSE SME |
| Face Value | 10 Rs. Per Share |
| Price | Rs.30 |
| Lot Size | 4000 |
| Issue Size | 4,000,000 shares (Rs. 12.00 Cr) |
| Fresh Issue | 4,000,000 shares (Rs. 12.00 Cr) |
| Listing Date | 30 June 2023 |
Vilin Bio Med Limited IPO Timetable:
| Activity | Date* |
|---|---|
| Opening Date | 16 June 2023 |
| Closing Date | 21 June 2023 |
| Allotment | 26 June 2023 |
| Initiation of Refunds | 27 June 2023 |
| Credit of Shares to Demat Account | 29 June 2023 |
| Listing Date | 30 June 2023 |
Company Financial Details:
| Period Ended | Assets | Revenue | Profit After Tax | Net Worth |
|---|---|---|---|---|
| 31 March 2020 | 1,400.60 | 1,682.41 | 16.22 | 724.13 |
| 31 March 2021 | 1,389.14 | 1,171.88 | 12.13 | 736.26 |
| 31 March 2022 | 1,355.83 | 1,121.91 | 3.35 | 739.61 |
| 31 December 2022 | 1,687.11 | 903.43 | 128.08 | 867.69 |
AS OF NOW, the GMP OF Vilin Bio Med Limited is Around Rs.